Please assess the completion status of the following clinical trial:

Trial Title: Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~HCV Positive With HCV RNA\>100,000 iu/ml Genotype 1; COHORT A- non responders or partial~Exclusion Criteria:~HIV HBV co-infection Decompensated liver disease Liver disease due to causes other than HCV, AFP\>200ng/ml

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Cohort B (Type: EXPERIMENTAL): None
- Cohort A (Type: EXPERIMENTAL): Dose study drug in subjects who have previously failed to respond to interferon based therapies

Based on this trial design, predict the completion outcome and termination type (if applicable).